Agglomeration of mesoporous silica by melt and steam granulation. Part I: a comparison between disordered and ordered mesoporous silica.

The objective of this study was to compare agglomerations by melt and steam granulation of ordered, COK-12, and disordered, Syloid(®) 244 FP (244), mesoporous silica material. Poloxamer 188 (P188) and polyvinylpyrrolidone K25 (PVP) were chosen as binders for melt and steam granulation, respectively. The poorly water-soluble compound, itraconazole (ITZ), was selected for the development of an immediate-release oral dosage form. Steam granulation resulted in the largest granules, however, the slowest release. Compression behavior and tablet properties of steam-granulated material prepared with COK-12 and 244 were similar. As determined by X-ray powder diffraction, melt granulation resulted in the most ITZ to extract from the pores during processing. However, the enhanced release rate was still maintained when compared with the crystalline form. Moreover, no additional drug extraction was observed following the 6 month storage in 25°C/60% relative humidity (RH) and 40°C/75%RH. P188 diffraction peaks were present in the 244 melt-granulated material, but disappeared because of the degradation following 1 week in 40°C/75%RH conditions. The differential scanning calorimetry analysis indicated that the degradation of P188 already occurred during the granulation process itself. Based on these results, steam granulation with PVP is the preferred method over melt granulation with P188.

[1]  Phillip Gribbon,et al.  High-throughput drug discovery: what can we expect from HTS? , 2005, Drug discovery today.

[2]  Beatrice Albertini,et al.  Melt granulation of pharmaceutical powders: a comparison of high-shear mixer and fluidised bed processes. , 2010, International journal of pharmaceutics.

[3]  C. Cavallari,et al.  Wet granulation as innovative and fast method to prepare controlled release granules based on an ion-exchange resin. , 2008, Journal of pharmaceutical sciences.

[4]  J. Humbeeck,et al.  Aging behavior of pharmaceutical formulations of itraconazole on SBA-15 ordered mesoporous silica carrier material , 2010 .

[5]  C. Jackson,et al.  Vitrification and Crystallization of Organic Liquids Confined to Nanoscale Pores , 1996 .

[6]  J. Martens,et al.  Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs. , 2011, Therapeutic delivery.

[7]  Johan Martens,et al.  Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug release. , 2011, Journal of pharmaceutical sciences.

[8]  K. Gubbins,et al.  Freezing behavior in porous glasses and MCM-41 , 2001 .

[9]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[10]  I. Smirnova,et al.  Tableting properties of silica aerogel and other silicates , 2012, Drug development and industrial pharmacy.

[11]  B. Erlandsson Stability-indicating changes in poloxamers: the degradation of ethylene oxide-propylene oxide block copolymers at 25 and 40 °C , 2002 .

[12]  C. Mijangos,et al.  Confinement effects on the crystallization of poly(ethylene oxide) nanotubes. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[13]  J. van Humbeeck,et al.  Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[14]  R. Pellenq,et al.  Adsorption, intrusion and freezing in porous silica: the view from the nanoscale. , 2013, Chemical Society reviews.

[15]  María Vallet-Regí,et al.  Mesoporous materials for drug delivery. , 2007, Angewandte Chemie.

[16]  Jesse Zhu,et al.  Characterization of powder flow: Static and dynamic testing , 2009 .

[17]  B. J. Ennis,et al.  Nucleation, growth and breakage phenomena in agitated wet granulation processes: a review , 2001 .

[18]  Leslie Z Benet,et al.  The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development. , 2013, Journal of pharmaceutical sciences.

[19]  C. Cavallari,et al.  Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[20]  María Vallet-Regí,et al.  New developments in ordered mesoporous materials for drug delivery , 2010 .

[21]  H. Santos,et al.  Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. , 2011, International journal of pharmaceutics.

[22]  J. D’Haen,et al.  Convenient synthesis of ordered mesoporous silica at room temperature and quasi-neutral pH , 2009 .

[23]  H. Santos,et al.  Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. , 2011, Journal of pharmaceutical sciences.

[24]  E. Barrett,et al.  The Determination of Pore Volume and Area Distributions in Porous Substances. II. Comparison between Nitrogen Isotherm and Mercury Porosimeter Methods , 1951 .

[25]  J. P. Olivier,et al.  Standard Nitrogen Adsorption Data for Characterization of Nanoporous Silicas , 1999 .

[26]  Patrick Augustijns,et al.  Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[27]  Hirofumi Takeuchi,et al.  Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method. , 2005, International journal of pharmaceutics.

[28]  M. Hasegawa,et al.  Effect of size distribution on tapping properties of fine powder , 2001 .

[29]  J. Devoisselle,et al.  Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  Koen Binnemans,et al.  Investigation of thermal properties of glassy itraconazole: identification of a monotropic mesophase , 2001 .

[31]  J. Martens,et al.  Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  Beatrice Albertini,et al.  Improved dissolution behaviour of steam-granulated piroxicam. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  R. Bogner,et al.  Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. , 2012, Journal of pharmaceutical sciences.

[34]  E. Barrett,et al.  (CONTRIBUTION FROM THE MULTIPLE FELLOWSHIP OF BAUGH AND SONS COMPANY, MELLOX INSTITUTE) The Determination of Pore Volume and Area Distributions in Porous Substances. I. Computations from Nitrogen Isotherms , 1951 .